Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Ganser Syndrome Treatment & Management

  • Author: Daniel Schneider, MD, MA; Chief Editor: Eduardo Dunayevich, MD  more...
 
Updated: Nov 11, 2015
 

Medical Care

Inpatient treatment may be needed during the acute phase. This is often necessary to protect the patient from himself or herself considering his or her dissociation. Treat any underlying medical conditions.

Admit the patient to a psychiatric facility if the patient is a danger to self or others.

Simple supportive psychotherapy and monitoring for safety are the chief components of treatment. Limited evidence exists that hypnosis or ECT may be useful.

Recovery usually is within days for most patients, especially if precipitating stress resolves.

Next

Consultations

Consultation with a neurologist is advisable to rule out neurologic etiologic factors.

Consultation with a psychiatrist is recommended initially and in follow-up.

Previous
Next

Activity

Restrict general activity to allow close observation during the acute phase of the syndrome.

Upon recovery, regular activities may be resumed.

Previous
 
 
Contributor Information and Disclosures
Author

Daniel Schneider, MD, MA Assistant Professor of Neurology, Division of Movement Disorders and Behavioral Neurology, Medical Director for Neurologic and Psychiatric Deep Brain Stimulation, Rutgers Robert Wood Johnson Medical School

Disclosure: Nothing to disclose.

Coauthor(s)

Robert C Daly, MB, ChB, MPH Senior Fellow, Department of Behavioral Endocrinology, National Institute of Mental Health, National Institutes of Health

Disclosure: Nothing to disclose.

Brian R Szetela, MD Assistant Professor, Department of Psychiatry, University of Massachusetts Medical School; Consulting Psychiatrist, Psychiatric Consultation - Liaison Service, University of Massachusetts Memorial Medical Center

Brian R Szetela, MD is a member of the following medical societies: American Psychiatric Association, American Society of Addiction Medicine, International Society for ECT and Neurostimulation

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Eduardo Dunayevich, MD Executive Director, Clinical Development, Amgen

Eduardo Dunayevich, MD is a member of the following medical societies: Schizophrenia International Research Society

Disclosure: Received salary from Amgen for employment; Received stock from Amgen for employment.

Additional Contributors

Alan D Schmetzer, MD Professor Emeritus, Department of Psychiatry, Indiana University School of Medicine

Alan D Schmetzer, MD is a member of the following medical societies: American Academy of Addiction Psychiatry, American Academy of Clinical Psychiatrists, American Academy of Psychiatry and the Law, American Association for Physician Leadership, American Medical Association, American Psychiatric Association, International Society for ECT and Neurostimulation, American Neuropsychiatric Association

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Can M Savasman, MD to the development and writing of this article.

References
  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.

  2. Ruggles AH. Observations on Ganser's Syndrome. American Journal of Insanity. 1905. 62:307-311.

  3. Enoch MD, Trethowan WH. The Ganser syndrome. Uncommon Psychiatric Syndromes. 1979. 50-62.

  4. Snyder SL, Buchsbaum MS, Krishna RC. Unusual visual symptoms and Ganser-like state due to cerebral injury: a case study using (18)F-deoxyglucose positron emission tomography. Behav Neurol. 1998. 11(1):51-54. [Medline].

  5. Merckelbach H, Peters M, Jelicic M, Brands I, Smeets T. Detecting malingering of Ganser-like symptoms with tests: a case study. Psychiatry Clin Neurosci. 2006 Oct. 60(5):636-8. [Medline].

  6. Andersen HS, Sestoft D, Lillebaek T. Ganser syndrome after solitary confinement in prison: a short review and a case report. Nord J Psychiatry. 2001. 55(3):199-201. [Medline].

  7. Carney MW, Chary TK, Robotis P. Ganser syndrome and its management. Br J Psychiatry. 1987 Nov. 151:697-700. [Medline].

  8. Dalfen AK, Anthony F. Head injury, dissociation and the Ganser syndrome. Brain Inj. 2000 Dec. 14(12):1101-5. [Medline].

  9. Epstein RS. Ganser syndrome, trance logic, and the question of malingering. Psychiatric Annals. 1991 Apr. 21(4):238-44.

  10. Ladowsky-Brooks RL, Fischer CE. Ganser symptoms in a case of frontal-temporal lobe dementia: is there a common neural substrate?. J Clin Exp Neuropsychol. 2003 Sep. 25(6):761-8. [Medline].

  11. Lee HB, Koenig T. A case of Ganser syndrome: organic or hysterical?. Gen Hosp Psychiatry. 2001 Jul-Aug. 23(4):230-1. [Medline].

  12. McEvoy, Campbell T. Ganser-like signs in carbon monoxide encephalopathy. Am J Psychiatry. 1977 Dec. 134(12):1448-9. [Medline].

  13. Miller P, Bramble D, Buxton N. Case study: Ganser syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997 Jan. 36(1):112-5. [Medline].

  14. Shorer CE. The Ganser Syndrome. British Journal of Criminology. Apr 1965. 5:120-131.

  15. Sigal M, Altmark D, Alfici S. Ganser syndrome: a review of 15 cases. Compr Psychiatry. 1992 Mar-Apr. 33(2):134-8. [Medline].

  16. Tost H, Wendt CS, Schmitt A, Heinz A, Braus DF. Huntington's disease: phenomenological diversity of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry. Am J Psychiatry. 2004 Jan. 161(1):28-34. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.